Free Trial

Insider Buying: Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Director Buys 7,000 Shares of Stock

Sabra Health Care REIT logo with Finance background

Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Get Free Report) Director Catherine Cusack bought 7,000 shares of Sabra Health Care REIT stock in a transaction on Wednesday, May 22nd. The stock was acquired at an average cost of $14.43 per share, with a total value of $101,010.00. Following the acquisition, the director now owns 46,385 shares of the company's stock, valued at approximately $669,335.55. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Sabra Health Care REIT Price Performance

Sabra Health Care REIT stock traded down $0.17 during midday trading on Thursday, reaching $14.15. 1,663,113 shares of the company were exchanged, compared to its average volume of 2,004,970. The company has a market capitalization of $3.28 billion, a price-to-earnings ratio of 70.75, a P/E/G ratio of 2.42 and a beta of 1.17. The firm's 50-day simple moving average is $14.24 and its 200-day simple moving average is $14.08. Sabra Health Care REIT, Inc. has a 1 year low of $10.30 and a 1 year high of $14.92. The company has a debt-to-equity ratio of 0.89, a quick ratio of 4.33 and a current ratio of 4.33.

Sabra Health Care REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 31st. Investors of record on Monday, May 20th will be given a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 8.48%. The ex-dividend date is Friday, May 17th. Sabra Health Care REIT's dividend payout ratio is presently 600.00%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on SBRA shares. Deutsche Bank Aktiengesellschaft started coverage on Sabra Health Care REIT in a report on Tuesday, January 30th. They issued a "buy" rating and a $21.00 target price for the company. Scotiabank raised their target price on Sabra Health Care REIT from $14.00 to $15.00 and gave the company a "sector perform" rating in a report on Wednesday, May 15th. Finally, Wedbush reaffirmed an "outperform" rating and set a $17.00 price target on shares of Sabra Health Care REIT in a research note on Thursday, February 29th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $15.71.


Read Our Latest Research Report on Sabra Health Care REIT

Institutional Trading of Sabra Health Care REIT

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. increased its position in Sabra Health Care REIT by 2.5% during the 1st quarter. Vanguard Group Inc. now owns 34,972,611 shares of the real estate investment trust's stock worth $516,545,000 after purchasing an additional 838,654 shares in the last quarter. Principal Financial Group Inc. increased its position in Sabra Health Care REIT by 0.4% during the 1st quarter. Principal Financial Group Inc. now owns 21,571,121 shares of the real estate investment trust's stock worth $318,605,000 after purchasing an additional 83,842 shares in the last quarter. JPMorgan Chase & Co. increased its position in Sabra Health Care REIT by 709.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 13,504,420 shares of the real estate investment trust's stock worth $188,252,000 after purchasing an additional 11,835,109 shares in the last quarter. Janus Henderson Group PLC grew its holdings in Sabra Health Care REIT by 2.9% in the 1st quarter. Janus Henderson Group PLC now owns 5,199,682 shares of the real estate investment trust's stock valued at $76,701,000 after buying an additional 145,548 shares during the period. Finally, LSV Asset Management grew its holdings in Sabra Health Care REIT by 2.5% in the 4th quarter. LSV Asset Management now owns 4,385,615 shares of the real estate investment trust's stock valued at $62,583,000 after buying an additional 107,266 shares during the period. Hedge funds and other institutional investors own 99.40% of the company's stock.

About Sabra Health Care REIT

(Get Free Report)

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Sabra Health Care REIT right now?

Before you consider Sabra Health Care REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Health Care REIT wasn't on the list.

While Sabra Health Care REIT currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Buy or Bail? Stock Upgrades and Downgrades

Buy or Bail? Stock Upgrades and Downgrades

In this "Buy or Bail?" video, we're diving deep into the latest stock upgrades and downgrades in the past quarter.

Related Videos

Cathie Wood’s AMD Buy: Smart Move or Risky Business
Micron Stock is the NVIDIA of Memory
NVIDIA’s Explosive Growth: Why the AI Leader’s Rally Isn’t Over Yet

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines